Development and validation of the coronary heart disease scale under the system of quality of life instruments for chronic diseases QLICD-CHD: combinations of classical test theory and Generalizability theory
机构:[1]School of Humanities and Management, Guangdong Medical College, Dongguan 523808, China.[2]Shilong Boai Hospital Affiliated to Guangdong Medical College, Dongguan 523325, China.[3]Guangzhou Health Education Institute, Guangzhou 510403, China.[4]The First Affiliated Hospital of Kunming Medical University, Kunming 650031, China.昆明医科大学附属第一医院[5]Shenzhen Futian District Institute for Prevention and Control of Chronic Diseases, Shenzhen 518048, China.[6]School of Medicine, Xi’An Jiaotong University, Xi’An 710049, China.
Background: Quality of life (QOL) for patients with coronary heart disease (CHD) is now concerned worldwide with the specific instruments being seldom and no one developed by the modular approach. Objectives: This paper is aimed to develop the CHD scale of the system of Quality of Life Instruments for Chronic Diseases (QLICD-CHD) by the modular approach and validate it by both classical test theory and Generalizability Theory. Methods: The QLICD-CHD was developed based on programmed decision procedures with multiple nominal and focus group discussions, in-depth interview, pre-testing and quantitative statistical procedures. 146 inpatients with CHD were used to provide the data measuring QOL three times before and after treatments. The psychometric properties of the scale were evaluated with respect to validity, reliability and responsiveness employing correlation analysis, factor analyses, multi-trait scaling analysis, t-tests and also G studies and D studies of Genralizability Theory analysis. Results: Multi-trait scaling analysis, correlation and factor analyses confirmed good construct validity and criterion-related validity when using SF-36 as a criterion. The internal consistency a and test-retest reliability coefficients (Pearson r and Intra-class correlations ICC) for the overall instrument and all domains were higher than 0.70 and 0.80 respectively; The overall and all domains except for social domain had statistically significant changes after treatments with moderate effect size SRM (standardized response mea) ranging from 0.32 to 0.67. G-coefficients and index of dependability (phi coefficients) confirmed the reliability of the scale further with more exact variance components. Conclusions: The QLICD-CHD has good validity, reliability, and moderate responsiveness and some highlights, and can be used as the quality of life instrument for patients with CHD. However, in order to obtain better reliability, the numbers of items for social domain should be increased or the items' quality, not quantity, should be improved.
基金:
National Natural Science Foundation of China (30860248,
71373058), Science and Technological Program for Dongguan’s Higher
Education, Science and Research, and Health Care Institutions
(2011105102008), the Key Discipline and Science & Technology Innovation
Fund of Guangdong Medical College (XZ1111, STIF201119).
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类|4 区医学
小类|3 区卫生保健与服务
最新[2023]版:
大类|2 区医学
小类|2 区卫生保健与服务2 区卫生政策与服务
JCR分区:
出版当年[2014]版:
Q2HEALTH POLICY & SERVICESQ2HEALTH CARE SCIENCES & SERVICES
最新[2023]版:
Q1HEALTH CARE SCIENCES & SERVICESQ1HEALTH POLICY & SERVICES
第一作者机构:[1]School of Humanities and Management, Guangdong Medical College, Dongguan 523808, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Wan Chonghua,Li Hezhan,Fan Xuejin,et al.Development and validation of the coronary heart disease scale under the system of quality of life instruments for chronic diseases QLICD-CHD: combinations of classical test theory and Generalizability theory[J].HEALTH AND QUALITY OF LIFE OUTCOMES.2014,12:doi:10.1186/1477-7525-12-82.
APA:
Wan, Chonghua,Li, Hezhan,Fan, Xuejin,Yang, Ruixue,Pan, Jiahua...&Zhao, Rong.(2014).Development and validation of the coronary heart disease scale under the system of quality of life instruments for chronic diseases QLICD-CHD: combinations of classical test theory and Generalizability theory.HEALTH AND QUALITY OF LIFE OUTCOMES,12,
MLA:
Wan, Chonghua,et al."Development and validation of the coronary heart disease scale under the system of quality of life instruments for chronic diseases QLICD-CHD: combinations of classical test theory and Generalizability theory".HEALTH AND QUALITY OF LIFE OUTCOMES 12.(2014)